Novel neurotransmitters and their neuropsychiatric relevance.

OBJECTIVE The purpose of this review is to integrate insights regarding novel neurotransmitters or neuromodulators of neuropsychiatric significance. METHOD Evolving concepts of neurotransmitter criteria are reviewed in light of the unexpected properties displayed by recently identified transmitters. RESULTS Classic criteria for transmitters were based on the properties of acetylcholine but were markedly revised with the recognition of the catecholamines, serotonin, gamma-aminobutyric acid (GABA), and other amino acid transmitters and neuropeptides. Nitric oxide and carbon monoxide are notably atypical, as they are not stored in synaptic vesicles, are not released by exocytosis, and do not act at postsynaptic membrane receptor proteins. D-Serine, recently appreciated as the endogenous ligand for the glycine site of the glutamate N-methyl-D-aspartate (NMDA) receptor, overturns fundamental axioms of biology as well as those of neuroscience. It is a D-amino acid, and it is synthesized and stored in glia rather than neurons. Released glutamate acts on receptors on the protoplasmic astrocytes closely apposed to the synapse to release D-serine, which coactivates postsynaptic NMDA receptors together with glutamate. D-Serine is formed by serine racemase, which directly converts L-serine to D-serine. Inhibitors of this enzyme should reduce NMDA neurotransmission and might be therapeutic in stroke and other conditions associated with glutamate excitotoxicity. CONCLUSIONS The diversity of novel neurotransmitters and venues of their activity afford multiple opportunities for therapeutic intervention.

[1]  P. Wood,et al.  Presence of the N‐Methyl‐D‐Aspartate‐Associated Glycine Receptor Agonist, D‐Seine, in Human Temporal Cortex: Comparison of Normal, Parkinson, and Alzheimer Tissues , 1993, Journal of neurochemistry.

[2]  N. Berger.  Poly(ADP-ribose) in the cellular response to DNA damage. , 1985, Radiation research.

[3]  J. Hibbs,et al.  L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. , 1987, Journal of immunology.

[4]  G. Boeckxstaens,et al.  Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter , 1990, Nature.

[5]  R. Trifiletti.  Neuroprotective effects of NG-nitro-L-arginine in focal stroke in the 7-day old rat. , 1992, European journal of pharmacology.

[6]  S H Snyder,et al.  Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Axelrod.  Noradrenaline: fate and control of its biosynthesis. , 1971, Science.

[8]  M J Peach,et al.  Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. , 1992, The Journal of biological chemistry.

[9]  S. Snyder,et al.  Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. , 1994, Science.

[10]  P. Ascher,et al.  Glycine potentiates the NMDA response in cultured mouse brain neurons , 1987, Nature.

[11]  N. Matsuki,et al.  The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. , 1997, Biochemical and biophysical research communications.

[12]  S. Snyder,et al.  Opiate receptor in normal and drug altered brain function* , 1975, Nature.

[13]  J. Newcomer,et al.  NMDA receptor hypofunction model of schizophrenia. , 1999, Journal of psychiatric research.

[14]  S. Snyder,et al.  Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase , 1995, Nature.

[15]  Yang Wang,et al.  Nitric oxide synthases: gene structure and regulation. , 1995, Advances in pharmacology.

[16]  S. Jaffrey,et al.  Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy , 2000, The Journal of clinical investigation.

[17]  S. Snyder,et al.  Heme Oxygenase-2 Is Neuroprotective in Cerebral Ischemia , 1999, Molecular medicine.

[18]  J. Krystal,et al.  D-serine and the therapeutic challenge posed by the N-methyl-D-aspartate antagonist model of schizophrenia. , 1998, Biological psychiatry.

[19]  D. Choi,et al.  Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.

[20]  G. Ronnett,et al.  Direct demonstration of a physiological role for carbon monoxide in olfactory receptor neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  D. Curtis,et al.  Genetic evidence for the neuronal nitric oxide synthase gene (NOS1) as a susceptibility locus for infantile pyloric stenosis. , 1996, American journal of human genetics.

[22]  Yang Wang,et al.  Structural organization of the human neuronal nitric oxide synthase gene (NOS1). , 1994, The Journal of biological chemistry.

[23]  M. Maines,et al.  Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. , 1986, The Journal of biological chemistry.

[24]  S. Snyder,et al.  Aggressive behavior in male mice lacking the gene for neuronal nitric oxide synthase requires testosterone , 1997, Brain Research.

[25]  S. Snyder,et al.  Effect of Nitric Oxide Synthase Inhibition on Cerebral Blood Flow and Injury Volume During Focal Ischemia in Cats , 1993, Stroke.

[26]  S. Gammie,et al.  Maternal Aggression Is Reduced in Neuronal Nitric Oxide Synthase-Deficient Mice , 1999, The Journal of Neuroscience.

[27]  J. E. Griffiths,et al.  The Akt kinase signals directly to endothelial nitric oxide synthase , 1999, Current Biology.

[28]  R. Roth,et al.  The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia , 1999, Neuropsychopharmacology.

[29]  T. Iwatsubo,et al.  D-aspartic acid localization during postnatal development of rat adrenal gland. , 1997, Biochemical and biophysical research communications.

[30]  P. Chessex,et al.  Influence of bilirubin on the antioxidant capacity of plasma in newborn infants. , 1997, Biology of the neonate.

[31]  A. Buisson,et al.  The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia , 1992, British journal of pharmacology.

[32]  S. Nakao,et al.  Reduction of depolarization-induced glutamate release by heme oxygenase inhibitor: Possible role of carbon monoxide in synaptic transmission , 1994, Neuroscience Letters.

[33]  G. Gourley.  Bilirubin metabolism and kernicterus. , 1997, Advances in pediatrics.

[34]  Sachio Takashima,et al.  Embryonic Development and Postnatal Changes in Free d‐Aspartate and d‐Serine in the Human Prefrontal Cortex , 1993, Journal of neurochemistry.

[35]  K N Sheth,et al.  Purification of serine racemase: biosynthesis of the neuromodulator D-serine. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. M. Di Fiore,et al.  Secretion of D‐aspartic acid by the rat testis and its role in endocrinology of the testis and spermatogenesis , 1998, FEBS letters.

[37]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[38]  B. Brüne,et al.  Phosphorylation of nitric oxide synthase by protein kinase A. , 1991, Biochemical and biophysical research communications.

[39]  O. Hornykiewicz.  Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.

[40]  S. Snyder,et al.  Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Snyder,et al.  Elimination of Aggressive Behavior in Male Mice Lacking Endothelial Nitric Oxide Synthase , 1999, The Journal of Neuroscience.

[42]  S. D. Brady,et al.  Haem oxygenase-1 prevents cell death by regulating cellular iron , 1999, Nature Cell Biology.

[43]  M. Moskowitz,et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.

[44]  T. Nagafuji,et al.  Blockade of nitric oxide formation by Nω-nitro-l-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats , 1992, Neuroscience Letters.

[45]  S. Snyder,et al.  Adenosine as a neuromodulator. , 1985, Annual review of neuroscience.

[46]  L. Ignarro,et al.  Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. , 1981, The Journal of pharmacology and experimental therapeutics.

[47]  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase , 1991 .

[48]  S. Daff,et al.  The 42-Amino Acid Insert in the FMN Domain of Neuronal Nitric-oxide Synthase Exerts Control over Ca2+/Calmodulin-dependent Electron Transfer* , 1999, The Journal of Biological Chemistry.

[49]  H. Krebs.  Metabolism of amino-acids: Deamination of amino-acids. , 1935, The Biochemical journal.

[50]  S. Snyder,et al.  Localization of nitric oxide synthase indicating a neural role for nitric oxide , 1990, Nature.

[51]  D. Spitz,et al.  Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. , 1998, The Journal of clinical investigation.

[52]  B. Ames,et al.  Antioxidant activity of albumin-bound bilirubin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[54]  S. Snyder,et al.  Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase , 1991, Neuron.

[55]  J. Garthwaite,et al.  Excitatory amino acid neurotoxicity and neurodegenerative disease. , 1990, Trends in pharmacological sciences.

[56]  S. Snyder,et al.  PIN: An Associated Protein Inhibitor of Neuronal Nitric Oxide Synthase , 1996, Science.

[57]  T. Iwatsubo,et al.  Immunohistochemical localization of D-aspartate in the rat pineal gland. , 1997, Biochemical and biophysical research communications.

[58]  M. Moskowitz,et al.  Ischemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[59]  P. Tempst,et al.  Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Garthwaite,et al.  NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. , 1989, European journal of pharmacology.

[61]  Steven Mark Miller,et al.  Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: evidence from genomic deletion of biosynthetic enzymes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[62]  L. Petrucelli,et al.  Regional decreases of free d-aspartate levels in Alzheimer's disease , 1998, Neuroscience Letters.

[63]  S. Tonegawa,et al.  Targeted gene deletion of heme oxygenase 2 reveals neural role for carbon monoxide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[64]  K. Abe,et al.  The possible role of hydrogen sulfide as an endogenous neuromodulator , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  A. Hashimoto,et al.  Free d-aspartate and d-serine in the mammalian brain and periphery , 1997, Progress in Neurobiology.

[66]  A. Lajtha,et al.  The presence of free D-aspartic acid in rodents and man. , 1986, Biochemical and biophysical research communications.

[67]  S. Schiffmann,et al.  Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. , 1992, The New England journal of medicine.

[68]  M. Maines,et al.  Purification and characterization of the major constitutive form of testicular heme oxygenase. The noninducible isoform. , 1986, The Journal of biological chemistry.

[69]  M. Chang,et al.  Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P. , 1970, The Journal of biological chemistry.

[70]  A. Giuditta,et al.  Presence of D‐aspartate in squid axoplasm and in other regions of the cephalopod nervous system , 1978, Journal of neurochemistry.

[71]  S. Snyder,et al.  Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.

[72]  M. Marletta,et al.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. , 1988, Biochemistry.

[73]  R. Meneghini.  Iron homeostasis, oxidative stress, and DNA damage. , 1997, Free radical biology & medicine.

[74]  S. Snyder,et al.  CAPON: A Protein Associated with Neuronal Nitric Oxide Synthase that Regulates Its Interactions with PSD95 , 1998, Neuron.

[75]  D. Bredt,et al.  Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains , 1996, Cell.

[76]  A. Neidle,et al.  Developmental changes in free D-aspartic acid in the chicken embryo and in the neonatal rat. , 1990, Life sciences.

[77]  S. Tonegawa,et al.  Heme oxygenase 1 is required for mammalian iron reutilization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[78]  G. Ronnett,et al.  Carbon Monoxide: An Endogenous Modulator of the Nitric Oxide–Cyclic GMP Signaling System , 1996, Neuron.

[79]  K. Fuxe,et al.  Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca. , 1966, Pharmacological reviews.

[80]  J. Cunningham,et al.  Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. , 1992, The Journal of biological chemistry.

[81]  Terry D. Lee,et al.  Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. , 1992, Science.

[82]  S. Snyder,et al.  D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[83]  S. Snyder,et al.  d-Serine as a Neuromodulator: Regional and Developmental Localizations in Rat Brain Glia Resemble NMDA Receptors , 1997, The Journal of Neuroscience.

[84]  W. Sessa,et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[85]  S. Snyder,et al.  Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[86]  S. Snyder,et al.  Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. , 1992, The Journal of biological chemistry.

[87]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[88]  B. Scatton,et al.  Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. , 1991, European journal of pharmacology.

[89]  R. Dingledine,et al.  Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. , 1988, Science.

[90]  Nicholas Lange,et al.  D-serine added to antipsychotics for the treatment of schizophrenia , 1998, Biological Psychiatry.

[91]  T. Hökfelt.  Neuropeptides in perspective: The last ten years , 1991, Neuron.

[92]  L. Petrucelli,et al.  Involvement of D-aspartic acid in the synthesis of testosterone in rat testes. , 1996, Life sciences.

[93]  J. Corrigan.  D-amino acids in animals. , 1969, Science.

[94]  M. Stark,et al.  Effect of nitric oxide on circular muscle of the canine small intestine. , 1991, The Journal of physiology.

[95]  S. Snyder,et al.  D-aspartate localizations imply neuronal and neuroendocrine roles. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[96]  Eric R Kandel,et al.  Long-Term Potentiation Is Reduced in Mice That Are Doubly Mutant in Endothelial and Neuronal Nitric Oxide Synthase , 1996, Cell.

[97]  G. Boeckxstaens,et al.  Non-adrenergic non-cholinergic relaxation mediated by nitric oxide in the canine ileocolonic junction. , 1990, European journal of pharmacology.

[98]  S. Amara,et al.  Neurotransmitter transporters: recent progress. , 1993, Annual review of neuroscience.

[99]  J. Schwartz,et al.  Histaminergic transmission in the mammalian brain. , 1991, Physiological reviews.

[100]  S. Snyder,et al.  Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia , 1999, Brain Research.

[101]  D. Linden,et al.  D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[102]  C. Nathan,et al.  Activated Murine Macrophages Secrete a Metabolite of Arginine with the Bioactivity of Endothelium-derived Relaxing Factor and the Chemical Reactivity of Nitric Oxide Materials and Methods , 2022 .

[103]  S. Snyder,et al.  Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[104]  H. Schulman,et al.  Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins , 1994, Neuron.

[105]  A. Giuditta,et al.  IDENTIFICATION OF D‐ASPARTIC ACID IN THE BRAIN OF OCTOPUS VULGARIS LAM , 1977, Journal of neurochemistry.

[106]  P. Roubertoux,et al.  Loss of Aggression, After Transfer onto a C57BL/6J Background, in Mice Carrying a Targeted Disruption of the Neuronal Nitric Oxide Synthase Gene , 2000, Behavior genetics.

[107]  S. Tonegawa,et al.  Ejaculatory abnormalities in mice with targeted disruption of the gene for heme oxygenase-2 , 1998, Nature Medicine.

[108]  F. Murad,et al.  Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. , 1991, Biochemical and biophysical research communications.

[109]  S. Snyder,et al.  Carbon monoxide: a putative neural messenger. , 1993, Science.

[110]  J. Garthwaite,et al.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain , 1988, Nature.

[111]  M. Camilleri,et al.  Pyloric dysfunction in diabetics with recurrent nausea and vomiting. , 1986, Gastroenterology.

[112]  T. Dawson,et al.  Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[113]  S. Snyder,et al.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[114]  J. Corbin,et al.  Cyclic GMP Phosphodiesterase-5: Target of Sildenafil* , 1999, The Journal of Biological Chemistry.

[115]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[116]  J. Szurszewski,et al.  Role of nitric oxide in gastrointestinal and hepatic function and disease. , 1992, Gastroenterology.

[117]  S. Tonegawa,et al.  Reduced stress defense in heme oxygenase 1-deficient cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[118]  B. Ames,et al.  Bilirubin is an antioxidant of possible physiological importance. , 1987, Science.

[119]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[120]  D. Krieger.  Brain peptides: what, where, and why? , 1983, Science.

[121]  T. Hökfelt,et al.  Chemical anatomy of the brain. , 1984, Science.

[122]  T. Quertermous,et al.  Cloning and expression of a cDNA encoding human endothelium-derived relating factor/nitric oxide synthase. , 1992, The Journal of biological chemistry.

[123]  S. Snyder,et al.  Targeted disruption of the neuronal nitric oxide synthase gene , 1993, Cell.

[124]  T. Nishikawa,et al.  Endogenous d‐Serine in Rat Brain: N‐Methyl‐d‐Aspartate Receptor‐Related Distribution and Aging , 1993, Journal of neurochemistry.

[125]  S. Snyder,et al.  Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[126]  S. Snyder,et al.  Poly (ADP-ribose) polymerase, nitric oxide and cell death. , 1999, Trends in pharmacological sciences.

[127]  G. Ronnett,et al.  The Regulation of Heme Turnover and Carbon Monoxide Biosynthesis in Cultured Primary Rat Olfactory Receptor Neurons , 1996, The Journal of Neuroscience.

[128]  Mark J. Thomas,et al.  Hippocampal long-term potentiation is normal in heme oxygenase-2 mutant mice , 1995, Neuron.

[129]  J. Wilcox,et al.  RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[130]  S. Snyder,et al.  Nitric oxide: a physiologic mediator of penile erection. , 1992, Science.

[131]  T. Quertermous,et al.  Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. , 1992, The Journal of biological chemistry.

[132]  H. Morris,et al.  Identification of two related pentapeptides from the brain with potent opiate agonist activity , 1975, Nature.

[133]  T. Nishikawa,et al.  Free d-serine, d-aspartate and d-alanine in central nervous system and serum in mutant mice lacking d-amino acid oxidase , 1993, Neuroscience Letters.

[134]  P. Kassander.  Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). , 1958, Annals of internal medicine.

[135]  S. Kombian,et al.  The actions of hydrogen sulfide on dorsal raphe serotonergic neurons in vitro. , 1993, Journal of neurophysiology.